Trubion Pharmaceuticals' Series B Round

Trubion Pharmaceuticals raised a round of funding on February 16, 2005.

Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. The Company's product candidates are novel proteins known as si…

Articles about Trubion Pharmaceuticals' Series B Round: